NUTX Nutex Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUTX

Price (delayed)

$186.81

Market cap

$1.28B

P/E Ratio

7.17

Dividend/share

N/A

EPS

$26.05

Enterprise value

$1.42B

?
Relative Growth: Rel. Growth: 77
Relative Strength: Rel. Strength: 92
Relative Valuation: Rel. Valuation: 97
Relative Profitability: Rel. Profitability: 98

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. ...

Highlights
NUTX's EPS has soared by 132% YoY and by 93% QoQ
The company's quick ratio has surged by 107% YoY and by 59% QoQ
The revenue is up by 7% year-on-year but it is down by 3.8% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.igambit.com

Key stats

What are the main financial stats of NUTX

NUTX stock price

How has the Nutex Health stock price performed over time
Intraday
8.33%
1 week
22.96%
1 month
4.28%
1 year
77.59%
YTD
13.48%
QTD
9.32%

Financial performance

How have Nutex Health's revenue and profit performed over time
Revenue
$846.72M
Gross profit
$434.03M
Operating income
$364.28M
Net income
$179.92M
Gross margin
51.3%
Net margin
21.2%
The net margin has soared by 199% YoY and by 93% from the previous quarter
The net income has soared by 87% since the previous quarter
NUTX's operating income has surged by 58% year-on-year and by 34% since the previous quarter
Nutex Health's operating margin has increased by 48% YoY and by 39% QoQ

Price vs fundamentals

How does NUTX's price correlate with its fundamentals

Growth

What is Nutex Health's growth rate over time

Valuation

What is Nutex Health stock price valuation
NUTX P/E details
P/E
7.17
P/B
3.26
P/S
1.52
EV/EBIT
5.24
EV/EBITDA
4.87
EV/Sales
1.68
NUTX's EPS has soared by 132% YoY and by 93% QoQ
NUTX's P/E is 14% below its last 4 quarters average of 8.3
NUTX's equity has soared by 68% YoY and by 14% from the previous quarter
The P/B is 25% above the last 4 quarters average of 2.6 but 4.1% below the 5-year quarterly average of 3.4
The stock's price to sales (P/S) is 52% more than its last 4 quarters average of 1.0 but 11% less than its 5-year quarterly average of 1.7
The revenue is up by 7% year-on-year but it is down by 3.8% since the previous quarter

Efficiency

How efficient is Nutex Health business performance
NUTX's ROA has soared by 125% YoY and by 80% from the previous quarter
NUTX's ROS has soared by 111% YoY and by 61% QoQ
Nutex Health's ROIC has soared by 86% YoY and by 51% from the previous quarter
Nutex Health's return on equity has surged by 65% QoQ and by 40% YoY

Dividends

What is NUTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUTX.

Financial health

How did Nutex Health financials performed over time
The total assets is 111% greater than the total liabilities
The company's quick ratio has surged by 107% YoY and by 59% QoQ
The current ratio has soared by 106% YoY and by 59% from the previous quarter
The debt is 12% less than the equity
NUTX's equity has soared by 68% YoY and by 14% from the previous quarter
The debt to equity has contracted by 40% YoY and by 13% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.